Blockchain Registration Transaction Record

Datavault AI Licenses Tech to Wellgistics, Taking on PBMs

Datavault AI (NASDAQ: DVLT) signs exclusive licensing deal with Wellgistics Health to deploy PharmacyChain platform, targeting PBM-driven drug pricing inefficiencies. Learn how this AI solution aims to lower costs.

This news matters because it targets the opaque pricing and rebate structures of pharmacy benefit managers (PBMs), which contribute to high U.S. drug costs. By licensing its AI-driven technology exclusively to Wellgistics Health for use in the PharmacyChain platform, Datavault AI aims to streamline prescription fulfillment and reduce reliance on traditional intermediaries. If successful, this could lower drug prices for patients and employers, while offering a more transparent and efficient supply chain. For investors, it highlights the growing potential of tech-driven solutions to disrupt entrenched healthcare systems.